Tenaya Therapeutics partners with Alnylam for heart disease targets
Go back to Tenaya Therapeutics partners with Alnylam for heart disease targets| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 236.22 +6.92 (3.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $229.30 | 52 Week High | $109.10 | |||
| Open | $228.88 | 52 Week Low | $31.38 | |||
| Day High | $238.97 | P/E | N/A | |||
| Day Low | $228.34 | EPS | $-1.45 | |||
| Volume | 1,906,391 | |||||
| (NASDAQ: TNYA) | Delayed: 0.70 +0.01 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.69 | 52 Week High | $ | |||
| Open | $0.69 | 52 Week Low | $ | |||
| Day High | $0.72 | P/E | N/A | |||
| Day Low | $0.69 | EPS | $ | |||
| Volume | 1,134,230 | |||||
